FDA Tightens Rules on Copycat Ozempic and Wegovy – No More Routine Compounding

FDA limits copycat GLP-1 drugs; pharmacies can only make them during shortages. Original meds like Foundayo now safer & more available.

FDA Tightens Rules on Copycat Ozempic and Wegovy – No More Routine Compounding
Credit: ISSAM AHMED/AFP
Already have an account? Sign in.